For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What is the projected market size of the hereditary genetic testing industry, and what is its expected CAGR?
The hereditary genetic testing market size has grown rapidly in recent years. It will grow from $21.47 billion in 2024 to $23.88 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to a rise in the incidence of inherited disease, growth in healthcare informatics, growth in telemedicine, growth in awareness campaigns, and a rising number of genetic testing platforms.
The hereditary genetic testing market size is expected to see rapid growth in the next few years. It will grow to $36.23 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising prevalence of genetic disorders, rising demand for diagnostics, increasing adoption of personalized medicine, and rising number of clinical trials. Major trends in the forecast period include technological advancements, whole-genome sequencing, integration of genetic data, personalized medicine, and non-invasive prenatal testing.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp
What external factors are influencing the hereditary genetic testing market’s growth momentum?
The increasing prevalence of cancer is expected to propel the growth of the hereditary genetic testing market going forward. Cancer refers to a collection of diseases marked by abnormal cell growth that can invade or spread to other parts of the body. The increasing prevalence of cancer can be attributed to factors such as aging populations, lifestyle changes, environmental pollutants, genetic predispositions, and improved diagnostic techniques. Hereditary genetic testing helps prevent cancer by identifying genetic mutations associated with increased risk, enabling early surveillance and targeted prevention strategies. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 156,781 in 2021 to 160,570 in 2022, reflecting a rise over the year. Therefore, the increasing prevalence of cancer is driving the growth of the hereditary genetic testing market.
What are the major market segments driving the growth of the hereditary genetic testing industry?
The hereditary genetic testing market covered in this report is segmented –
1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies
Subsegments:
1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes and Congenital Diseases, Diagnostic Testing For Cancer and Tumor Profiling
5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities and Side Effects, Personalized Medicine and Treatment Optimization
6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report
Which trends are expected to dominate the hereditary genetic testing market landscape in the coming years?
Major companies operating in the hereditary genetic testing market are focused on developing advanced genomic solutions, such as multi-cancer multigene panels, to enhance early detection and personalized treatment options. Multi-cancer multigene panels are diagnostic tests that analyze multiple genes simultaneously to detect genetic mutations associated with various types of cancer, aiding in early diagnosis and personalized treatment. For instance, in February 2024, Exact Sciences Corporation, a US-based provider of cancer screening and diagnostic tests, launched the Riskguard hereditary cancer test. The Riskguard test delivers a personalized report on gene-specific and familial cancer risks using a simple blood or saliva sample for 10 common cancers. It aids in understanding cancer risk, informing screening and treatment plans, and assessing family risks. Additionally, it helps tailor treatment for patients already diagnosed with cancer and enhances risk stratification for those with a family history of cancer by identifying actionable gene variants.
Who are the key market players contributing to the growth of the hereditary genetic testing industry?
Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.
Which regions are leading the growth of the hereditary genetic testing market globally?
North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Hereditary Genetic Testing Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20559
Need Customized Data On Hereditary Genetic Testing Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20559&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
